UK-based powder containment and aseptic transfer valve specialist ChargePoint Technology is expanding its US presence, following a multimillion dollar investment from private equity firm, LDC.
According to the company, demand from North America, Europe and Asia has fueled the need for the expansion of the firm’s support team within North America. A new office, based in San Francisco, brings the total number of global offices to four.
Chris Rombach, previously of ILC Dover, Pacific Ozone and Stedim Biotech (now part of Sartorius group) joins the team at the San Francisco office as president of ChargePoint Inc. He will be responsible for driving the growth of the entire company offering across the US, Canada, Mexico, and Puerto Rico. This will include the establishment of local sales operations and the creation of new roles in the US.